Hepatic neuroendocrine metastases: Chemo- or bland embolization?

Journal of Gastrointestinal Surgery

Volumn 12, Issue 11, 2008, Pages 1951-1960

  Pitt, Susan C ^a,b   Knuth, Jaime ^a   Keily, James M ^c   McDermott, John C ^d   Weber, Sharon M ^b   Chen, Hebert ^b   Rilling, William S ^c   Quebbeman, Edward J ^c   Agarwal, David M ^a   Pitt, Henry A ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chemoembolization; Embolization; Hepatic artery; Liver; Metastasis; Neuroendocrine tumor

Indexed keywords

ARTICLE; ARTIFICIAL EMBOLISM; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; KAPLAN MEIER METHOD; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEUROENDOCRINE TUMOR; NONPARAMETRIC TEST; PROBABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

CHEMOEMBOLIZATION, THERAPEUTIC; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 54349122462     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0640-6     Document Type: Article

References (44)

1. H Chen J Hardacre A Uzar J Cameron M Choti 1998 Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187 88 93
2. JG Touzios JM Kiely SC Pitt WS Rilling EJ Quebbeman SD Wilson 2005 Neuroendocrine hepatic meastases: does aggressive management improve survival? Ann Surg 241 776 785
3. S Musunuru H Chen S Rajpal N Stephani JC McDermott K Holen 2006 Metastatic neuroendocrine hepatic tumors: resection improves survival Arch Surg 141 1000 1004
4. KA Yoa MS Talamonti A Nemeck P Angelos H Chrisman J Skarda 2001 Indications and results of liver resection and hepatic chemoembolization for metastastic gastrointestinal neuroendocrine tumors Surgery 130 677 685
5. KJ Woodside CM Townsend Jr MB Evers 2004 Current management of gastrointestinal carcinoid tumors J Gastrointest Surg 8 742 756
6. KD Schupak KE Wallner 1991 The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors Int J Radiol Oncol Biol Phys 20 489 495
7. CM Townsend Jr JC Thompson 1996 The clinical use of gastrointestinal hormones for alimentary tract disease Adv Surg 29 79 92
8. FG Que DM Nagorney KP Batts 1995 Hepatic resection for metastatic neuroendocrine carcinomas Am J Surg 169 36 42
9. D O'Toole F Maire P Ruszniewski 2003 Ablative therapies for liver metastases of digestive endocrine tumors Endocr Relat Cancer 10 463 468
10. YP Le Treut JR Delpero B Dousset 1997 Results of liver transplantation in the treatment of metastatic neuroendocrine tumors: a 31-case French multicentric report Ann Surg 225 355 364
11. S Gupta MM Johnson R Murthy K Ahrar MJ Wallace DC Madhoff 2005 Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rate and survival Cancer 104 1590 1602
12. AT Ruutiainen MC Soulen CM Tuite TWI Clark JI Mandschein SW Stavropoulos 2007 Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver J Vasc Interv Radiol 18 847 855
13. A Lunderquist M Ericsson A Nobin G Sandén 1982 Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumors Radiologe 22 65 70
14. H Mårtensson A Nobin S Bengmark A Lunderquist T Owman G Sandén 1984 Embolization of the liver in the management of metastatic carcinoid tumors J Surg Oncol 27 152 158
15. F Stöckman HJ Von Romatowski WV Reimold R Schuster W Cruetzfeldt 1984 Hepatic artery embolization for the treatment of endocrine gastrointestinal tumors with liver metastases Z Gastroenterol 22 652 660
16. A Odurny SJ Birsch 1985 Hepatic arterial embolisation in patients with metastatic carcinoid tumours Clin Radiol 36 597 602
17. BK Eriksson EG Larsson BM Skogseid Am Löfberg LE Lörelius KE Oberg 1998 Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors Cancer 83 2293 2301
18. KT Brown BY Koh LA Brody GI Getrajdman J Susman Y Fong 1999 Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms J Vasc Interv Radiol 10 397 403
19. RS Chamberlain D Canes KT Brown L Saltz W Jarnagin Y Fong 2000 Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll 190 432 435
20. SR Schell ER Camp JG Caridi IF Hawkins Jr 2002 Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors J Gastrointest Surg 6 664 670
21. JR Strosberg J Choi AB Cantor LK Kvols 2006 Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors Cancer Control 13 72 78
22. DA Osborne EE Zervos J Strosberg BA Boe M Malafa AS Rosemurgy 2006 Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors Ann Surg Oncol 13 572 581
23. D Granberg LG Eriksson S Welin H Kindmark ET Janson B Skogseid 2007 Liver embolization with trisacryl gelatin microshperes (embosphere) in patients with neuroendocrine tumors Acta Radiol 48 180 185
24. KR Stokes K Stuart ME Clouse 1993 Hepatic arterial chemoembolization for metastatic endocrine tumors J Vasc Interv Radiol 4 341 345
25. E Therasse F Breittmayer A Roche T DeBaere S Indushekar M Ducreux 1993 Transcatheter chemoembolization of progressive carcinoid liver metastases Radiology 189 541 547
26. ME Clouse L Perry K Stuart KR Stokes 1994 Hepatic arterial chemoembolization for metastatic neuroendocrine tumors Digestion 199 55 92 97
27. JG Drougas LB Anthony TK Blair RR Lopez JK Wright Jr WC Chapman 1998 Hepatic arterial chemoembolization for management of patients with advanced metastatic carcinoid tumors Am J Surg 175 408 412
28. S Dominguez A Denys I Madiera P Hammel V Vilgrain Y Menu 2000 Hepatic arterial chemoembolization with streptozocin in patients with metastatic digestive endocrine tumors Eur J Gastroenterol Hepatol 12 151 157
29. S Gupta JC Yao K Ahrar MJ Wallace FA Morello DC Madoff 2003 Hepatic arterial embolizationand chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience Cancer J 9 261 267
30. AS Ho J Picus MD Darcy B Tan JE Gould TK Pilgram 2007 Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors AJR Am J Roentgenol 188 1201 1207
31. CG Moertel CM Johnson MA McKusick JK Martin Jr DM Nagorney LK Kvols 1994 The management of patients with advanced carcinoid tumors and islet cell carcinomas Ann Intern Med 120 302 309
32. EW McDermott B Guduric MF Brennan 1994 Prognostic variables in patients with gastrointestinal carcinoid tumours Br J Surg 81 1007 1009
33. KO Shabani WW Souba DM Finkelstein PC Stark KM Elgadi KK Tenabe 1999 Prognosis and survival in patients with gastrointestinal tract carcinoid tumors Ann Surg 229 815 823
34. R Caprotti C Angelini C Mussi 2003 Gastrointestinal carinoids. Prognosis and survival Minerva Chir 58 523 532
35. KJ Woodside CM Townsend Jr MB Evers 2004 Current management of gastrointestinal carcinoid tumors J Gastrointest Surg 8 742 756
36. HJ Andreyev P Scott-Mackie D Cunningham V Nicolson AR Norman SS Badve 1995 Phase II study of continuous infusion fluorouracil and interferon alpha-2b in the palliation of malignant neuroendocrine tumors J Clin Oncol 13 1486 1492
37. MP Ducreux V Boige S Leboulleux 2006 A phase II study irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas Oncology 70 134 140
38. MA Kouvaraki JA Anjani P Hoff R Wolff DB Evans R Lozano 2004 Fuorouracil, doxorubicin, and streptozosin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas J Clin Oncol 22 4762 4771
39. E Bajetta L Catena G Procopio S De Dosso E Bichisao L Ferrari 2007 Are capecitabine and oxaliplatin (XELOX) suitable treatment for progressing low-grade and high-grade neuroendocrine tumours? Cancer Chemother Pharmacol 59 637 642
40. I Durán R Salazar O Casanovas V Arruzubi E Vilar LL Siu 2007 New drug development in digestive neuroendocrine tumors Ann Oncol 18 1307 1313
41. IM Modlin K Oberg DC Chung RT Jensen WW de Herder RV Thakker 2008 Gastroenteropancreatic neuroendocrine tumors Lancet Oncol 9 61 72
42. SN Pinchot SC Pitt RS Sippel M Kunnimalaiyaan H Chen 2008 Novel target for the treatment and palliation of gastrointestinal neuroendocrine tumors Curr Opin Investig Drugs 9 576 582
43. QD Chu HC Hill HO Douglass Jr D Driscoll JL Smith HR Nava 2002 Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas Ann Surg Oncol 9 855 862
44. JM Sarmiento G Heywood J Rubin 2003 Surgical treatment of neuroendocrine metastases to the liver: a plea for resction to increase survival J Am Coll Surg 197 29 37